stem cell transplantation – pharmaceutical daily

April 1, 2019 Off

Hematopoietic Stem Cell Transplantation – Pipeline Insight, 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Hematopoietic Stem Cell Transplantation – Pipeline Insight, 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. The report…

November 1, 2018 Off

Quicker pathway to a pivotal trial for larger patient population than planned for Actinium’s CD33

By Dino Mustafić

@ActiniumPharma moves to next stage of development for its CD33 ARC (Antibody Radiation Conjugate) Ac-225-Lintuzumab program are pivotal trial pathway for its Actimab-MDS program for Myelodysplastic Syndromes (MDS), and also in two combination trials with Venetoclax for AML.
$ATNM

March 17, 2017 Off

Nordic Nanovector kicks off phase 1 Betalutin study

By Dino Mustafić

Nordic Nanovector ASA has begin dosing patients in its Phase 1 Betalutin study, testing a CD37 targeting antibody-radionuclide conjugate, in patients with relapsed diffuse large B-cell lymphoma (DLBCL) who are ineligible for stem cell transplantation.